Related Experiment Video
Updated: Mar 6, 2026

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults
Debora Rizzuto1, René J F Melis2, Sara Angleman1
1Department of Neurobiology, Health Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Insights
Multimorbidity significantly reduces lifespan and quality of life in older adults, leading to more years lived with disability. This highlights the urgent need to address multiple chronic conditions in geriatric care.
Area of Science:
- Gerontology
- Public Health
- Epidemiology
Background:
- Chronic disorders are prevalent in older adults.
- Understanding their impact on survival and functioning is crucial for public health.
- Co-occurrence of diseases (multimorbidity) presents unique challenges.
Purpose of the Study:
- To determine the effect of chronic disorders and their co-occurrence on survival and functioning in community-dwelling older adults.
- To evaluate the burden of specific diseases and multimorbidity on mortality and life years lost.
- To assess the impact on years lived with disability.
Main Methods:
- Population-based cohort study in Kungsholmen, Stockholm, Sweden.
- Inclusion of 1,099 individuals aged 78 and older, followed over 11 years.
- Evaluation of chronic diseases and multimorbidity (≥2 coexisting chronic diseases) using ICD-10 codes.
Main Results:
- Multimorbidity affected 70.4% of the population, accounting for 69.3% of deaths and causing 7.5 years of life lost.
- Individuals with multimorbidity lived 81% of their remaining years with disability (median 5.2 years).
- Cardiovascular and neuropsychiatric diseases contributed significantly to mortality and years of life lost.
Conclusions:
- Survival length and quality in older adults vary based on specific chronic conditions.
- Multimorbidity has the most substantial negative impact on individual survival, dependence, and societal burden.
- Multimorbidity is identified as a critical clinical and public health priority.
Objectives:
To determine the effect of chronic disorders and their co-occurrence on survival and functioning in community-dwelling older adults.
Design:
Population-based cohort study.
Setting:
Kungsholmen, Stockholm, Sweden.
Participants:
Individuals aged 78 and older examined by physicians four times over 11 years (N = 1,099).
Measurements:
Chronic diseases (grouped according to 10 organ systems according to the International Classification of Diseases, Tenth Revision, code) and multimorbidity (≥2 coexisting chronic diseases) were evaluated in terms of mortality, population attributable risk of death, median years of life lost, and median survival time with and without disability (need of assistance in ≥1 activities of daily living).
Results:
Approximately one in four deaths were attributable to cardiovascular and one in six to neuropsychiatric diseases. Malignancy was the condition with the shortest survival time (2.5 years). Malignancies and cardiovascular disorders each accounted for approximately 5 years of life lost. In contrast, neurosensorial and neuropsychiatric conditions had the longest median survival time (>6 years), and affected people were disabled for more than half of this time. The most-prevalent and -burdensome condition was multimorbidity, affecting 70.4% of the population, accounting for 69.3% of total deaths, and causing 7.5 years of life lost. Finally, people with multimorbidity lived 81% of their remaining years of life with disability (median 5.2 years).
Conclusion:
Survival in older adults differs in length and quality depending on specific conditions. The greatest negative effect at the individual (shorter life, greater dependence) and societal (number of attributable deaths, years spent with disability) level was from multimorbidity, which has made multimorbidity a clinical and public health priority.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
The Effect of Aging on Tissues